Lidia Nieto‐Rodriguez

Institute for Research in Biomedicine

Papers

1

Total Citations

43

H-Index

1

About

Dr. Lidia Nieto-Rodriguez is a leading figure in synthetic organic chemistry, renowned for her transformative work in peptide synthesis methodology. Her research focuses on the development and mechanistic understanding of novel coupling reagents, with a particular emphasis on the Oxyma scaffold. Her most impactful contribution is her seminal 2013 study on COMU, a uronium salt that revolutionized peptide bond formation. This highly cited work (43 citations) systematically delineated the scope and limitations of COMU, establishing it as a groundbreaking alternative to classical reagents like HATU and HBTU. By demonstrating COMU’s superior efficiency, reduced racemization, and enhanced safety profile, Dr. Nieto-Rodriguez provided the scientific community with a powerful, practical tool for peptide acyl transfer. Her research has directly influenced both academic laboratories and industrial peptide synthesis, accelerating drug discovery and bioconjugation. Through her rigorous analysis of reagent performance, she has set a new standard for innovation in the field, cementing her legacy as a key architect of modern peptide chemistry.

Research Focus

Key Achievements

1
H-Index
1
Papers
43
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
COMU: scope and limitations of the latest innovation in peptide acyl transfer reagents
43 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Institute for Research in Biomedicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago